Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Disability and Health Journal|May 13, 2017
Individuals with mild MS with poor sleep quality have impaired visuospatial memory and lower perceived functional abilitiesCatherine F Siengsukon, Mayis Aldughmi, Melike Kahya, et al.
Multiple Sclerosis and Related Disorders|June 21, 2022
Social support predicts sleep quality in people with multiple sclerosis during the COVID-19 pandemicTaylor P Harris, Lauren M Zaeske, Rebecca Ludwig, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|June 5, 2018
How patients with multiple sclerosis weigh treatment risks and benefitsJared M Bruce, David P Jarmolowicz, Sharon Lynch, et al.
Journal of Behavioral Medicine|November 11, 2017
Baseline predictors of DMT reinitiation among patients with multiple sclerosis following an MI-CBT interventionJoanie Thelen, Amanda Bruce, Delwyn Catley, et al.
Marine Environmental Research|June 13, 2015
Neutral red retention time assay in determination of toxicity of nanoparticlesWentao Hu, Sarah Culloty, Grainne Darmody, et al.
Experimental and Clinical Psychopharmacology|September 27, 2019
Behavioral economic demand for medications and its relation to clinical measures in multiple sclerosisDavid P Jarmolowicz, Derek D Reed, Tadd D Schneider, et al.
Chemosphere|March 4, 2014
Toxicity of copper oxide nanoparticles in the blue mussel, Mytilus edulis: a redox proteomic investigationWentao Hu, Sarah Culloty, Grainne Darmody, et al.
Contemporary Clinical Trials Communications|February 2, 2026
Cognitive behavioral therapy for insomnia for individuals with multiple sclerosis (CALM): A randomized control trial protocolCatherine F Siengsukon, Jade Robichaud, Eryen Nelson, et al.
Psychopharmacology|September 24, 2018
Probability discounting of treatment decisions in multiple sclerosis: associations with disease knowledge, neuropsychiatric status, and adherenceJared M Bruce, Amanda S Bruce, Sharon Lynch, et al.
Experimental and Clinical Psychopharmacology|December 19, 2017
On how patients with multiple sclerosis weigh side effect severity and treatment efficacy when making treatment decisionsDavid P Jarmolowicz, Amanda S Bruce, Morgan Glusman, et al.
Pageof 5